EPISODE · Apr 4, 2008 · 9 MIN
The Lancet: April 04, 2008
from Listen to The Lancet · host The Lancet
Doubts over the long-term safety of the HIV nucleoside reverse transcriptase inhibitor abacavir and the less commonly used antiretroviral drug didanosine are raised in a research Article. Both drugs were found to be associated with an increased risk of myocardial infarction. Jens Lundgren (University of Copenhagen, Denmark) discusses the study in this week's podcast.
Embed this episode
NOW PLAYING
The Lancet: April 04, 2008
0:00
9:31
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Listen to The Lancet?
This episode is 9 minutes long.
When was this Listen to The Lancet episode published?
This episode was published on April 4, 2008.
Can I download this Listen to The Lancet episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!